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Abstract
Caffeic acid (CA) is a phenolic compound widely found in coffee beans with known benefi-
cial effects in vivo. Many studies showed that CA has anti-inflammatory, anti-mutagenic, an-
tibacterial and anti-carcinogenic properties, which could be linked to its antioxidant activity.
Taking in consideration the reported in vitro antioxidant mechanism of other polyphenols,
our working hypothesis was that the CA antioxidant activity could be related to its metal-che-
lating property. With that in mind, we sought to investigate the chemical antioxidant mecha-
nism of CA against in vitro iron-induced oxidative damage under different assay conditions.
CA was able to prevent hydroxyl radical formation promoted by the classical Fenton reac-
tion, as determined by 2-deoxyribose (2-DR) oxidative degradation and DMPO hydroxyl-
ation. In addition to its ability to prevent hydroxyl radical formation, CA had a great inhibition
of membrane lipid peroxidation. In the lipid peroxidation assays CA acted as both metal-
chelator and as hydrogen donor, preventing the deleterious action promoted by lipid-de-
rived peroxyl and alkoxyl radicals. Our results indicate that the observed antioxidant effects
were mostly due to the formation of iron-CA complexes, which are able to prevent 2-DR oxi-
dation and DMPO hydroxylation. Noteworthy, the formation of iron-CA complexes and pre-
vention of oxidative damage was directly related to the pH of the medium, showing better
antioxidant activity at higher pH values. Moreover, in the presence of lipid membranes the
antioxidant potency of CA was much higher, indicating its enhanced effectiveness in a hy-
drophobic environment. Overall, our results show that CA acts as an antioxidant through an
iron chelating mechanism, preventing the formation of free hydroxyl radicals and, therefore,
inhibiting Fenton-induced oxidative damage. The chemical properties of CA described here
—in association with its reported signaling effects—could be an explanation to its beneficial
effects observed in vivo.
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Introduction
Caffeic acid (CA) is a phenolic compound produced by the secondary metabolism of plants and
is the major hydroxycinnamic acid present in the human diet [1]. It is commonly found in sever-
al fruits and coffee beans, one of the major commodities consumed in the western diet [1]. Clif-
ford (2000) reported that the absorption of this compound is directly associated with the amount
of coffee consumed, being able to achieve 500 to 800 mg/day in individuals with high coffee in-
take [2]. In addition, several studies demonstrated that CA is absorbed in rat [3] and human in-
testines [4,5], where 95% of total CA ingested was absorbed. Several other studies showed that
plasmatic concentrations of polyphenols–including CA–are between 0.3 and 1.5 μM [6–9].
The antioxidant activity of CA was previously studied by different research groups
[9,10,11,12]. For instance, Nardini et al. reported that CA inhibited, in a dose-dependent man-
ner, human LDL lipoperoxidation induced by cupric ions [10]. The authors show that CA is
able to reduce lipoperoxyl radicals (ROO•)–by donating a hydrogen atom–to its corresponding
hydroperoxide, which inhibits the lipid peroxidation chain reaction. In addition to its antioxi-
dant capacity, studies have shown that CA has anti-inflammatory [11], anti-mutagenic [12],
antibacterial [13] and anti-carcinogenic properties [14].
Several detailed studies were conducted to determine the ability of CA, and its metabolites,
to bind metal ions and to study their influence on redox reactions mediated by these metals
[15–17]. Moon and Terao (1998) reported the antioxidant activity of CA and dihydrocaffeic
acid (H2CA) on human LDL oxidation induced by copper ions, where both antioxidants ex-
tended the lipoperoxidation initiation phase [18]. Moreover, the authors saw that CA and
H2CA inhibited the formation of methyl linoleate hydroperoxides induced by the azo-iniatiator
AMVN (2.2’-Azobis-2.4-dimethylvaleronitrile) [18]. Noteworthy, H2CA was detected in
human plasma as a cathecol metabolite of CA [19].
Despite the numerous studies reporting the antioxidant properties of CA, the exact antioxi-
dant mechanism in systems containing iron ions remains unclear. Thus, this study was con-
ducted to characterize the ability of CA to complex iron ions as well as the antioxidant activity
of this complex in several oxidant systems. Briefly, we observed that CA is able to complex Fe
(II) ions and to inhibit in vitroDMPO hydroxylation (an EPR assay), 2-deoxyribose (2-DR) ox-
idation (both are assays for hydroxyl radical formation) and lipid peroxidation of rat liver
membranes. Our results also show that the antioxidant activity is dependent on the medium




Caffeic acid, 2-deoxyribose (2-DR), potassium phosphate, 5,5-Dimethyl-1-Pyrroline-N-Oxide
(DMPO) and thiobarbituric acid (TBA) were purchased from Sigma. Ferric chloride, H2O2
and ferrous ammonium sulfate were fromMerck. Other reagents were of analytical grade.
Phosphate buffer (pH 7.2) and solutions of 2-DR were prepared weekly, while solutions of
metal chelators (0.5 mM), Fe(II) (0.5 mM) and H2O2 (1 mM) were prepared prior to use. De-
ionized water (Millipore; ρ 18 MΩ cm) was used for all solutions. DMPO was purified prior
to the experiments. TBA solutions (1% w/v) were prepared daily in 50 mMNaOH.
Animal care and ethics statement
Experiments were performed at University of Brasilia. Two adult male Wistar rats were provid-
ed by Dr. Egle de Almeida’s Laboratory located at the University of Brasilia, Brazil. They were
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housed individually in stainless steel cages for two days under controlled conditions (21–23°C,
12 hour light/dark cycles) and were allowed water and food ad libitum. Rats were then sacri-
ficed by cervical dislocation and livers were excised, washed in a cold 0.9% NaCl solution, rap-
idly frozen in liquid nitrogen and stored at −80°C for further analyses. This protocol was
approved by the Ethics Committee for the Use of Animals of the Institute of Biological Sci-
ences, University of Brasilia, Brazil as UnB-DOC 120380/2009.
Spectrophotometric determinations of Fe(II)-CA complexes
Analyses were carried out in a Hitachi U-2001 spectrophotometer using a 10 mm path-length
cuvette. Reactions were carried out in the presence of 10 mM phosphate buffer (pH 7.2), CA
and Fe(II). Spectra were obtained immediately after the addition of iron. Absorbances were
subtracted from respective blanks.
2-Deoxyribose oxidation
The method is based on the determination of malondialdehyde (MDA) [20,21], a degradation
product of 2-DR oxidation. Typical reactions were started by the addition of Fe(II) to solutions
(0.5 mL final volume) containing 5 mM 2-DR, 10 mM phosphate (pH 7.2), CA and H2O2. Re-
actions were carried out for 10 min at 25 ± 1°C and stopped by the addition of 0.5 mL 4% phos-
phoric acid plus 0.5 mL TBA solution. After boiling (15 min), absorbances were measured at
532 nm [21].
Electron Paramagnetic Resonance
EPR spectra were obtained with a Bruker-EMX spectrometer equipped with the standard
(ER4102) rectangular resonator operating in the TE102 mode. Samples of the mixtures were
transferred to capillary tubes (volume, 50 μL) and measured at room temperature. Instrument
settings: microwave frequency, 9.42 GHz; microwave power, 10 mW; field-modulation fre-
quency, 100 kHz; field-modulation amplitude, 1.0 G; receiver gain, 1.25 x 105; time constant,
41 ms; scan rate, 2.5 G s-1; number of scans: 3. Spectra were registered 3 min after Fe(II) addi-
tion to solutions containing 10 mM phosphate (pH 7.2), 50 mMDMPO in the presence or ab-
sence of CA.
Lipid Peroxidation
Analyses were done using total rat liver homogenate and quantifying TBARS. Livers from two
Wistar rats were homogenized with cold phosphate buffer (50 mM plus KCl 125 mM) in a 1:4
w/v ratio. This mixture was centrifuged at 1000 rpm for 15 min at 4°C, then the supernatant
was used for assays. Typical reactions were started by addition of Fe(II) to solutions (0.5 mL
final volume) containing 10 mM phosphate (pH 7.2), 5% v/v rat liver homogenate, KCl 125
mM, CA and H2O2. Reactions were performed at 24–25°C and stopped by 0.2 mL 7% phospho-
ric acid plus 0.2 mL TBA solution. After boiling for 15 min, solutions were cooled and absor-
bance values were measured at 532 and 600 nm. The final “readings” were obtained by
subtracting A532 from A600.
Results
Spectrophotometric analyses of Fe(II)-CA complex
The formation of iron-CA complex can be observed in 604 nm and it is directly associated with
its ability to bind iron ions through the catechol moiety [22]. CA was incubated with Fe(II) in
different buffered media (at pHs 4.0, 5.5 and 7.2) to test the pH influence on the complex
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formation. Fig 1A shows that complexation is influenced by pH, with higher complex-forma-
tion values at pH 7.2 than at 4.0 or 5.5. The higher the absorbance values, the higher the metal
complexation. In order to determine the complexation rate, a kinetic study was also performed
(Fig 1B). The formation of the complex was monitored at 604 nm and the absorbance values
were recorded until 105 min. There is no effect at pH 4.0, suggesting that CA does not complex
Fe(II) through the cathecol moiety. At pH 5.5 the complexation is detectable within 1 min and
reaches saturation after 30 min, indicating that the reaction reached the equilibrium. At pH 7.2
the complexation reaches its maximum within 10 sec, remaining unchanged through the entire
incubation, indicating that the complexation through the catechol moiety happens very quickly
at this pH.
Influence of the pH on the 2-DR damage
After characterizing the complex formation we performed an experiment to test the pH influ-
ence on the antioxidant capacity of CA. Fig 1C shows that the antioxidant effect of CA against
2-DR damage–induced by Fenton reagents—is pH dependent. At pH 5.5 the antioxidant effi-
ciency afforded by CA was only 36%, much lower than at pH 7.2 (86% protection).
Effect of CA concentration
The effect of CA on hydroxyl radical formation from Fenton reagents (H2O2 100 μM plus Fe
(II) 50 μM) was determined employing the EPR assay of DMPO hydroxylation (Fig 2). The an-
tioxidant action of CA was concentration dependent, with a two-phase inhibitory profile and
maximum inhibitory action happed from 0 to 0.1 mM CA (Fig 3A). A similar result—employ-
ing the same concentrations of Fenton reagents—was observed when the CA titration was de-
termined using the 2-DR assay (Fig 4). For both assays, 0.2 mM CA presented a near-maximal
inhibitory effect.
Effect of iron concentration
CA also inhibited DMPO hydroxylation, induced by Fenton reagents, with different concentra-
tions of iron. Moreover, in the presence of 50 μM Fe(II), CA inhibited EPR signal by 31% (Fig
3B). A comparison experiment with TA (a polyphenol with 25 free hydroxyl groups, possessing
a better environment for iron chelation and/or hydroxyl radical scavenging activity[23])
Fig 1. Spectroscopic analyses of CA. (A) Visible spectra at different pHs for mixtures of CA and Fe(II). Experimental conditions: 8 mM Hepes/MES; 8 μM
Fe(II); 80 μMCA; figure shows representative spectra (n = 3). (B) Time course of CA and Fe(II) complexation at pHs 7.2 (■), 5.6 (●) and 4.0 (▲). Experimental
conditions: 20 mM Hepes/MES; 30 μMFe(II); 200 μMCA; figure shows representative traces (n = 3). (C) Effect of pH on 2-DR degradation induced by
Fenton reagents in the absence (dark bars) or presence of CA (light bars). Experimental conditions: 20 mM Hepes/Mes; 10 mM 2-DR; 30 μMFe(II); 100 μM
H2O2; 200 μMCA. n = 9.
doi:10.1371/journal.pone.0129963.g001
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showed the same profile with the increase in Fe(II) concentration, except the percent of protec-
tion was increased to 53% (data not shown). In addition, the effect of iron concentration on
CA antioxidant action was also examined using the 2-DR assay. It is observed that an augment
in Fe(II) concentration is accompanied by a decrease in the antioxidant efficiency of CA (re-
ferred as percentage at Fig 3B).
Effect of 2-DR concentration
In order to characterize the antioxidant mechanism of CA we performed a competition experi-
ment in the presence of different 2-DR concentrations (Table 1). Briefly, this experiment con-
sists in increasing the hydroxyl radical target molecule (2-DR in this case) and monitors the
percent of inhibition. If CA and 2-DR shall compete for the hydroxyl radical, the inhibition
performed by CA would decrease with the increase in 2-DR concentration, suggesting a scav-
enger antioxidant molecule. It can be seen that CA prevented 2-DR oxidation in all
Fig 2. Typical EPR signal of DMPO-OH adduct induced by Fenton reagents. Signal obtained in the
absence of CA (upper signal) and in the presence of 100 μMCA (bottom signal). Experimental conditions: 10
mM KPi (pH 7.2); 20 mM DMPO; 100 μMH2O2; 50 μM Fe(II). Signal is representative of three independent
experiments;
doi:10.1371/journal.pone.0129963.g002
Fig 3. EPR determinations of DMPO hydroxylation induced by Fenton reagents. (A) Effect of CA on
DMPO hydroxylation. Experimental conditions: 10 mM KPi (pH 7.2); 20 mMDMPO; 100 μMH2O2; 50 μM Fe
(II); 0–300 μMCA. n = 3; (B) Effect of Fe(II) on DMPO hydroxylation in the absence (solid squares) or
presence (open squares) of CA. Experimental conditions: 10 mM KPi; 20 mM DMPO; 100 μMH2O2; 200 μM
CA; 0–100 μM Fe(II). n = 3.
doi:10.1371/journal.pone.0129963.g003
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experimental conditions. In addition, the raise in 2-DR concentration did not influence the rel-
ative CA effect, since in all conditions the percent of inhibition remained unchanged.
Effect of CA on lipid peroxidation
CA antioxidant effect was also analyzed against lipid peroxidation. Hepatic membranes were
incubated for 3.5 h with Fenton reagents in the absence and presence of different CA concen-
trations (Fig 5A). CA inhibited lipid peroxidation in a dose-dependent manner, and at 150 μM
reached a similar efficiency of 100 μM BHT (a well-known chain breaking antioxidant). We
also analyzed the effect of CA concentration on the peroxidation lag phase (Fig 5B). The lag
phase of control reaction was 4 min, being expanded 10 and 25 times with 100 μM and 150 μM
CA, respectively. The propagation phase of the peroxidation reaction (also known as the log
phase) had its rate decreased from 2.7 x 10−3 A/min to 0.5 x 10−3 A/min at 100 μM, and to ap-
proximately 0.1 x 10−3 A/min at 150 μM (Fig 5C). In addition, CA inhibited TBARS formation
after 3 h incubation by 72 and 87% when employed at 100 and 150 μM, respectively (Fig 4A).
50 μMCA had no effect on the lag-phase, but decreased the rate of the log phase by 59% and
the levels of peroxidation (at 3 h incubation) by 41%.
Fig 4. Effect of CA on 2-DR oxidative degradation induced by Fenton reagents. Experimental
conditions: 10 mM KP (pH 7.2)i; 5 mM 2-DR; 100 μMH2O2; 50 μM Fe(II); 0–350 μMCA. n = 3. The angular
coefficient changes at 100 μMCA, suggesting a 1:2 Fe(II):CA complexation ratio.
doi:10.1371/journal.pone.0129963.g004
Table 1. Effect of 2-DR concentration in the 2-DR oxidation assay.
[2-DR] mM Experimental conditions
A532 without CA A532 with CA % of protection
0 0.002 ± 0.004 0.000 ± 0.003 —-
5 0.125 ± 0.028 0.100 ± 0.031 20.5%
10 0.158 ± 0.040 0.127 ± 0.034 19.4%
20 0.173 ± 0.030 0.135 ± 0.041 22.0%
Experimental conditions: 10 mM KPi (pH 7.2), 30 μM Fe(II) (or Fe(III) for the blanks), 100 μM H2O2, 200 μM CA and 0 to 20 mM 2-DR. The reaction was
incubated for 10 min after addition of Fe(II). n = 6. Absorbance values were corrected for the effect of Fe(III)-induced 2-DR oxidation (see [19]).
doi:10.1371/journal.pone.0129963.t001
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Discussion
The pH influence on the complex formation (Fig 1A) is related to CA’s three ionizable hydrox-
yl groups, with pKa values of 4.8, 8.6 and 11.2 (carboxylic group, p-hydroxy andm-hydroxy
hydrogens, respectively) [24]. The increase in the medium pH (from 4.0 to 7.2) leads to an en-
hancement on the dissociation of these groups and, consequently, the ability of CA to chelate
iron is also increased (which is also observed in the kinetic experiment–Fig 1B). The lack of
complexation through the cathecol moiety at pH 4.0 is due to the fact that such pH is lower
than the pKa of the carboxylic group and a negligible amount of the cathecol groups is deproto-
nated (see pKa values at Fig 6), making the complexation an unfavorable process.
At pH 5.5 the carboxylate ion (situation B at Fig 6) is the major species present in solution
and the equilibrium also involves the deprotonation of the second hydroxyl group (p-hydroxy).
This situation would enhance the ability of CA to bind iron ions [24]. The increase in the pH
to 7.2 favors even more the ionization of the p-hydroxyl group, once the pH is closer to its pKa
value. Moreover, the fast complexation at pH 7.2 (within 10 sec) may be due to the initial bind-
ing between Fe(II) and the p-hydroxyl group, enhancing the electronic density over the aro-
matic ring and stabilizing the complex. This could lower the pKa of the other hydroxyl group
(m-hydroxyl) and facilitate the second bond between CA and Fe(II). Pardo-Andreu et al.
(2006) made a similar proposal for mangiferin—a molecule bearing a cathecol moiety and sev-
eral other hydroxyl groups—during iron complexation [25]. Furthermore, Kunsági-Mati et al.
(2008) reported the formation of a thermodynamic favorable complex (ΔG0 = -18.6 kJ/mol)
with a 1:1 Fe(II):CA ratio at pH 3.2, in which is suggested that CA binds Fe(II) through the
Fig 5. Effect of caffeic acid on lipid peroxidation. (A) Effect of CA on the in vitro rat liver peroxidation induced by Fenton reagents. Experimental
conditions: 10 mM KPi (pH 7.2); 5% v/v liver homogenate; 100 μMH2O2; 50 μM Fe(II) (■); Fe(II) plus 50 μMCA (●); Fe(II) plus 100 μMCA (▲); Fe plus 150 μM
CA (▼); Fe plus 100 μMBHT (□). n = 9; (B) Effect of CA on the lag phase of lipid peroxidation. (C) Effect of CA on the log phase of peroxidation—experimental
conditions are the same as in panel-A.
doi:10.1371/journal.pone.0129963.g005
Fig 6. Deprotonation of caffeic acid and the respective pKa values.
doi:10.1371/journal.pone.0129963.g006
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carboxylate moiety [26]. It is worth mentioning that we did not observe the complexation be-
tween CA and Fe(II) at pH 4.0 because we were monitoring it through the absorbance of cathe-
col moiety. In addition to the 1:1 ratio, CA may complex iron ions with other stoichiometries,
such as 1:2 and 1:3 Fe(II):CA, which is pH-dependent and is expected to have higher antioxi-
dant effect [27]. Indeed, the antioxidant activity of CA is influenced by the medium pH, with
an increase in its efficiency with the augment in the pH (see Fig 1C).
As shown in Fig 3A, the titration of CA has a two-phase antioxidant profile (the same be-
havior is observed employing the 2-DR assay–Fig 4). Fe(II) was present in 50 μM in both ex-
periments and the graph angular coefficient changed when CA reached 100 μM. It is worth
noticing that higher CA concentrations had no further effect on its antioxidant activity. This
may suggest that CA is chelating Fe(II) in a 1:2 Fe(II):CA ratio, since higher CA concentrations
had little influence on the DMPO-OH signal and on the 2-DR degradation. Noteworthy, since
there is an excess of CA in solution regarding iron irons, the occurrence of more saturated
complex species is also possible. For instance, CA could also form complexes with stoichiome-
try 1:3 Fe:CA, a more likely situation, since iron(II) ions prefer octahedral geometrical environ-
ments. Moreover, the behavior observed in Fig 3A could also be due to a saturation effect of
the signal when the metal-ligand species are formed. Apparently, an increase in the iron con-
centration could change the pattern of the complexation, probably by the iron coordination on
the other hydroxyl groups (see reference [25] for more details).
Observations from Ginani (2005) regarding the polyphenol ellagic acid (a molecule bearing
two cathecol groups), showed that its antioxidant activity is pH-dependent against Fenton-in-
duced oxidative damage [28]. Increasing the medium pH from 5.5 to 8.0 promoted a higher
iron chelation and also an improvement in the antioxidant activity exhibited by the polyphe-
nol. These observations taken as a whole indicate that in higher pHs the deprotonation of the
cathecol groups is more elevated which, in turn, favors iron chelation, thus improving the ca-
pacity of CA to inhibit ROS formation. Altogether, these results strongly suggest that the mech-
anism for antioxidant action of CA is associated with the formation of the iron complex which,
somehow, inhibits the reaction between hydroxyl radical and the target molecule (2-DR or
DMPO).
The inverse relation between iron concentration and in vitro antioxidant action observed in
Fig 3B was also reported for the case of TA, mangiferin and PIH [25,29,30]. These competition
assays suggest that the inhibitory action on 2-DR degradation or DMPO hydroxylation was
linked to the capacity of these molecules (including CA) to chelate iron ions. Thus, the higher
the metal concentration in the media the lower is the ability of CA–and other iron chelating an-
tioxidants–to form an iron-complex and prevent hydroxyl radical-mediated target oxidation.
This indicates that the antioxidant capacity of CA is due to the formation of complexes with
metal ions, capable of preventing in vitro oxidative damage.
In order to further characterize the antioxidant mechanism of CA an experiment varying
the 2-DR concentration was performed (Table 1). This experiment allows the differentiation
between the radical scavenger and the metal chelating mechanisms [31]. The scavenger mecha-
nism is based on the reaction of the antioxidant directly with the hydroxyl radical, characteriz-
ing a competition system. Hence, an augment in the 2-DR concentration would cause a
decrease in the percent of inhibition (of 2-DR degradation), since more hydroxyl radical would
react more with the target molecule. However, if the antioxidant acts as chelator, complexing
metal ions and preventing “free hydroxyl radical” formation, the percent of inhibition would
not be altered when the target molecule concentration is increased. As shown in Table 1 the
percent of inhibition remained unchanged in all 2-DR concentrations, a behavior strongly con-
sistent with the metal chelator mechanism of antioxidant action. Similar conclusions were
made by Hermes-Lima et al. (2000) [31], Andrade Jr et al. (2006) [23] and Pardo-Andreu et al.
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(2006) [25] when studying the antioxidant mechanisms of PIH, TA and mangiferin, respective-
ly. On the other hand, incubations of Fe(II) plus H2O2 (6 μM and 100 μM, respectively) with
“classical” scavenger molecules, such as mannitol and thiourea (both in milimolar concentra-
tions), show that the percent of inhibition decreases with the augment in the 2-DR concentra-
tion (from 3 to 70 mM) [29]. This decrease in the percent of inhibition in the oxidation of a
target molecule is a characteristic behavior of molecules bearing a scavenger antioxidant mech-
anism. It is worth mentioning that, despite several studies show that polyphenols, including
CA, have antioxidant properties, this is the first study that clearly indicates that the antioxidant
activity of this phenolic compound is influenced by the medium pH and its mechanism is relat-
ed to its ability to form complexes with iron that prevent target oxidation by hydroxyl radicals.
Despite many studies–including ours–showing that polyphenols act as antioxidant against
metal-mediated free radical generation, some studies show the reverse effect [32]. For instance,
Mauryan and Devasagayam (2010) reported that CA could act as a pro-oxidant species in sys-
tems containing Fe(III) ions, H2O2 and ascorbic acid. The authors attribute this capacity to a
reducing ability of CA. In our conditions, however, we did not notice such behavior, which
could be related to differences in the experimental conditions, including: i) we used Fe(II) in-
stead of Fe(III); ii) there was no ascorbic acid in our incubations.
The antioxidant effect of CA against membrane lipid peroxidation was more pronounced
than on the other systems, in which it prevented the peroxidation in lower concentrations (Fig
5A) (the other systems are based on assays for hydroxyl radical formation). This higher antiox-
idant activity could be due to the hydrophobicity of CA, which would increase its antioxidant
activity in a lipophilic environment (e.g., cell membrane). In this system, CA could intercalate
between the phospholipids present in biological membranes, acting as a peroxyl radical scaven-
ger. Moreover, CA could chelate iron ions in the membrane microenvironment, preventing
both initiation and propagation of lipid peroxidation. In this sense, CA prolonged the lag
phase of lipid peroxidation in a dose-dependent manner (Fig 5B), suggesting a peroxyl radical
scavenger mechanism [33]. This mechanism is well known for several molecules, including
BHT, that are usually capable of donating a hydrogen atom to peroxyl radicals (for more de-
tails, see reference [34]). Moreover, CA also decreased the rate of the propagation phase of
lipid peroxidation (log phase) in a dose-dependent manner (Fig 5C). This indicates that the an-
tioxidant mechanism also involves iron complexation by CA, which prevents their participa-
tion in the propagation cascade.
These results altogether point toward a chelating mechanism of CA, in which it binds to
iron ions and prevent the oxidative consequences of the Fenton reaction, including lipid perox-
idation, DMPO hydroxylation and 2-DR damage. Since iron ions are mostly not “free” inside
the cell (it is bound to proteins and low molecular weight ligands, such as citrate [35]), the anti-
oxidant properties of CA reported herein might occur in the gastro-intestinal tract, a place
where iron ions are highly absorbed. In this scenario, CA could act preventing oxidative dam-
age promoted by iron and other transition metals. Moreover, studies analyzing the polyphenol
concentration, including CA, in the blood of coffee drinking individuals indicated its presence
in the low micromolar range [4,8,9], which gives it the capability to act in the cell membrane
microenvironment of different tissues preventing lipid peroxidation and other oxidative pro-
cesses mediated by lipid peroxidation products.
In addition to the antioxidant effect per se, evidences have been published indicating the ef-
fects of CA and its derivatives (for example, 3-(3,4-dihydroxy-phenyl)-acrylic acid 2-(3,4-dihy-
droxy-phenyl)-ethyl ester—CADPE) on gene expression [36]. Several studies reported the
tumor suppression and potential therapeutic effects of CA in vivo [37]. For instance, Chung
et al (2004) demonstrated that CA suppressed the tumor growth and liver metastasis in mice
by down-regulating NF-kB and MMP-9 genes [36]. Indeed, such molecules were reported to
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down-regulate NF-kB in many cell-culturing experiments. Furthermore, it has been shown
that CA and its derivatives are also able to enhance Nrf2 production, which would end up im-
proving cellular antioxidant response [38–42]. Even though gene expression was out of the
scope of our study, it is important to mention that both mechanisms—modulation of gene ex-
pression and antioxidant activity—may explain the beneficial health effects of CA.
In conclusion, our results strongly suggest that CA works in vitro by efficiently chelating
iron ions and, thus, minimizing the effects of Fenton-generated hydroxyl radicals, including
lipid peroxidation. Overall, we believe that the detailed chemical study presented here will ex-
pand the knowledge about the chemistry of caffeic acid, which might shed light on the biologi-
cal functions of this molecule (as well as other phenolic compounds).
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